Dna X (SONM) Payables (2018 - 2025)
Historic Payables for Dna X (SONM) over the last 8 years, with Q3 2025 value amounting to $25.2 million.
- Dna X's Payables rose 17854.46% to $25.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $25.2 million, marking a year-over-year increase of 17854.46%. This contributed to the annual value of $22.8 million for FY2024, which is 1512.07% up from last year.
- Latest data reveals that Dna X reported Payables of $25.2 million as of Q3 2025, which was up 17854.46% from $23.5 million recorded in Q2 2025.
- Dna X's Payables' 5-year high stood at $25.2 million during Q3 2025, with a 5-year trough of $8.1 million in Q2 2022.
- Over the past 5 years, Dna X's median Payables value was $16.3 million (recorded in 2021), while the average stood at $16.2 million.
- Per our database at Business Quant, Dna X's Payables crashed by 6105.95% in 2024 and then soared by 17854.46% in 2025.
- Dna X's Payables (Quarter) stood at $9.5 million in 2021, then surged by 123.01% to $21.1 million in 2022, then fell by 6.05% to $19.8 million in 2023, then grew by 15.12% to $22.8 million in 2024, then increased by 10.4% to $25.2 million in 2025.
- Its Payables stands at $25.2 million for Q3 2025, versus $23.5 million for Q2 2025 and $19.6 million for Q1 2025.